Bill
A 1236
Establishes "New Jersey Right to Try-Plus Act" permitting terminally ill patients access to certain investigational and off-label treatments.
2024-2025 Regular Session
Introduced by Dawn Fantasia and 1 co-sponsor
New Jersey bill expands terminal patients' access to experimental and off-label drugs outside FDA-approved clinical trials, balancing patient autonomy against safety oversight concerns.
Introduced in the Assembly, Referred to Assembly Health Committee